195 related articles for article (PubMed ID: 37794492)
1. Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Neumann A; Ohlei O; Küçükali F; Bos IJ; Timsina J; Vos S; Prokopenko D; Tijms BM; Andreasson U; Blennow K; Vandenberghe R; Scheltens P; Teunissen CE; Engelborghs S; Frisoni GB; Blin O; Richardson JC; Bordet R; Lleó A; Alcolea D; Popp J; Marsh TW; Gorijala P; Clark C; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Van Broeckhoven C; Tanzi RE; Ten Kate M; Lill CM; Barkhof F; Cruchaga C; Lovestone S; Streffer J; Zetterberg H; Visser PJ; Sleegers K; Bertram L;
Genome Med; 2023 Oct; 15(1):79. PubMed ID: 37794492
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association reveals genetic effects on human Aβ42 and τ protein levels in cerebrospinal fluids: a case control study.
Han MR; Schellenberg GD; Wang LS;
BMC Neurol; 2010 Oct; 10():90. PubMed ID: 20932310
[TBL] [Abstract][Full Text] [Related]
3. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
Hong S; Dobricic V; Ohlei O; Bos I; Vos SJB; Prokopenko D; Tijms BM; Andreasson U; Blennow K; Vandenberghe R; Gabel S; Scheltens P; Teunissen CE; Engelborghs S; Frisoni G; Blin O; Richardson JC; Bordet R; ; Lleó A; Alcolea D; Popp J; Clark C; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Tanzi RE; Ten Kate M; Wittig M; Franke A; Lill CM; Barkhof F; Lovestone S; Streffer J; Zetterberg H; Visser PJ; Bertram L
Alzheimers Dement; 2021 Oct; 17(10):1628-1640. PubMed ID: 33991015
[TBL] [Abstract][Full Text] [Related]
4. Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation.
Neumann A; Küçükali F; Bos I; Vos SJB; Engelborghs S; De Pooter T; Joris G; De Rijk P; De Roeck E; Tsolaki M; Verhey F; Martinez-Lage P; Tainta M; Frisoni G; Blin O; Richardson J; Bordet R; Scheltens P; Popp J; Peyratout G; Johannsen P; Frölich L; Vandenberghe R; Freund-Levi Y; Streffer J; Lovestone S; Legido-Quigley C; Ten Kate M; Barkhof F; Strazisar M; Zetterberg H; Bertram L; Visser PJ; van Broeckhoven C; Sleegers K;
Mol Psychiatry; 2022 Apr; 27(4):1990-1999. PubMed ID: 35173266
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset.
Hong S; Prokopenko D; Dobricic V; Kilpert F; Bos I; Vos SJB; Tijms BM; Andreasson U; Blennow K; Vandenberghe R; Cleynen I; Gabel S; Schaeverbeke J; Scheltens P; Teunissen CE; Niemantsverdriet E; Engelborghs S; Frisoni G; Blin O; Richardson JC; Bordet R; Molinuevo JL; Rami L; ; Kettunen P; Wallin A; Lleó A; Sala I; Popp J; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Ten Kate M; Barkhof F; Zetterberg H; Lovestone S; Streffer J; Wittig M; Franke A; Tanzi RE; Visser PJ; Bertram L
Transl Psychiatry; 2020 Nov; 10(1):403. PubMed ID: 33223526
[TBL] [Abstract][Full Text] [Related]
6. Genetic loci associated with Alzheimer's disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort.
Elias-Sonnenschein LS; Helisalmi S; Natunen T; Hall A; Paajanen T; Herukka SK; Laitinen M; Remes AM; Koivisto AM; Mattila KM; Lehtimäki T; Verhey FR; Visser PJ; Soininen H; Hiltunen M
PLoS One; 2013; 8(4):e59676. PubMed ID: 23573206
[TBL] [Abstract][Full Text] [Related]
7. Sex-specific genetic predictors of Alzheimer's disease biomarkers.
Deming Y; Dumitrescu L; Barnes LL; Thambisetty M; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Huentelman M; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Moghekar A; Del Aguila JL; Fernandez MV; Budde J; Hassenstab J; Fagan AM; Riemenschneider M; Petersen RC; Minthon L; Chao MJ; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Peskind ER; Li G; Davis LK; Sealock JM; Cox NJ; ; ; Goate AM; Bennett DA; Schneider JA; Jefferson AL; Cruchaga C; Hohman TJ
Acta Neuropathol; 2018 Dec; 136(6):857-872. PubMed ID: 29967939
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide network-based pathway analysis of CSF t-tau/Aβ1-42 ratio in the ADNI cohort.
Cong W; Meng X; Li J; Zhang Q; Chen F; Liu W; Wang Y; Cheng S; Yao X; Yan J; Kim S; Saykin AJ; Liang H; Shen L;
BMC Genomics; 2017 May; 18(1):421. PubMed ID: 28558704
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide association study of CSF biomarkers Abeta1-42, t-tau, and p-tau181p in the ADNI cohort.
Kim S; Swaminathan S; Shen L; Risacher SL; Nho K; Foroud T; Shaw LM; Trojanowski JQ; Potkin SG; Huentelman MJ; Craig DW; DeChairo BM; Aisen PS; Petersen RC; Weiner MW; Saykin AJ;
Neurology; 2011 Jan; 76(1):69-79. PubMed ID: 21123754
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
Deming Y; Li Z; Kapoor M; Harari O; Del-Aguila JL; Black K; Carrell D; Cai Y; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Huang KL; Bertelsen S; Fagan AM; Holtzman DM; Morris JC; Kim S; Saykin AJ; De Jager PL; Albert M; Moghekar A; O'Brien R; Riemenschneider M; Petersen RC; Blennow K; Zetterberg H; Minthon L; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Schellenberg G; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Peskind ER; Li G; Di Narzo AF; ; ; Kauwe JS; Goate AM; Cruchaga C
Acta Neuropathol; 2017 May; 133(5):839-856. PubMed ID: 28247064
[TBL] [Abstract][Full Text] [Related]
11. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
[TBL] [Abstract][Full Text] [Related]
12. Quantitative Genetics Validates Previous Genetic Variants and Identifies Novel Genetic Players Influencing Alzheimer's Disease Cerebrospinal Fluid Biomarkers.
Ramos de Matos M; Ferreira C; Herukka SK; Soininen H; Janeiro A; Santana I; Baldeiras I; Almeida MR; Lleó A; Dols-Icardo O; Alcolea D; Benussi L; Binetti G; Paterlini A; Ghidoni R; Nacmias B; Meulenbroek O; van Waalwijk van Doorn LJC; Kuiperi HBJ; Hausner L; Waldemar G; Simonsen AH; Tsolaki M; Gkatzima O; Resende de Oliveira C; Verbeek MM; Clarimon J; Hiltunen M; de Mendonça A; Martins M
J Alzheimers Dis; 2018; 66(2):639-652. PubMed ID: 30320580
[TBL] [Abstract][Full Text] [Related]
13. Association Between Common Variants of APOE, ABCA7, A2M, BACE1, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: Data from the PUMCH Dementia Cohort.
Dong L; Mao C; Liu C; Li J; Huang X; Wang J; Lei D; Chu S; Sha L; Xu Q; Peng B; Cui L; Gao J
J Alzheimers Dis; 2022; 85(4):1511-1518. PubMed ID: 34958020
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide association study of CSF levels of 59 alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation.
Kauwe JS; Bailey MH; Ridge PG; Perry R; Wadsworth ME; Hoyt KL; Staley LA; Karch CM; Harari O; Cruchaga C; Ainscough BJ; Bales K; Pickering EH; Bertelsen S; ; Fagan AM; Holtzman DM; Morris JC; Goate AM
PLoS Genet; 2014 Oct; 10(10):e1004758. PubMed ID: 25340798
[TBL] [Abstract][Full Text] [Related]
15. Effects of Alzheimer's disease-associated risk loci on cerebrospinal fluid biomarkers and disease progression: a polygenic risk score approach.
Martiskainen H; Helisalmi S; Viswanathan J; Kurki M; Hall A; Herukka SK; Sarajärvi T; Natunen T; Kurkinen KM; Huovinen J; Mäkinen P; Laitinen M; Koivisto AM; Mattila KM; Lehtimäki T; Remes AM; Leinonen V; Haapasalo A; Soininen H; Hiltunen M
J Alzheimers Dis; 2015; 43(2):565-73. PubMed ID: 25096612
[TBL] [Abstract][Full Text] [Related]
16. Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
Hohman TJ; Dumitrescu L; Barnes LL; Thambisetty M; Beecham G; Kunkle B; Gifford KA; Bush WS; Chibnik LB; Mukherjee S; De Jager PL; Kukull W; Crane PK; Resnick SM; Keene CD; Montine TJ; Schellenberg GD; Haines JL; Zetterberg H; Blennow K; Larson EB; Johnson SC; Albert M; Bennett DA; Schneider JA; Jefferson AL;
JAMA Neurol; 2018 Aug; 75(8):989-998. PubMed ID: 29801024
[TBL] [Abstract][Full Text] [Related]
17. Chitinase-3-like 1 protein (CHI3L1) locus influences cerebrospinal fluid levels of YKL-40.
Deming Y; Black K; Carrell D; Cai Y; Del-Aguila JL; Fernandez MV; Budde J; Ma S; Saef B; Howells B; Bertelsen S; Huang KL; Sutphen CL; Tarawneh R; Fagan AM; Holtzman DM; Morris JC; Goate AM; Dougherty JD; Cruchaga C
BMC Neurol; 2016 Nov; 16(1):217. PubMed ID: 27832767
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
Jansen IE; van der Lee SJ; Gomez-Fonseca D; de Rojas I; Dalmasso MC; Grenier-Boley B; Zettergren A; Mishra A; Ali M; Andrade V; Bellenguez C; Kleineidam L; Küçükali F; Sung YJ; Tesí N; Vromen EM; Wightman DP; Alcolea D; Alegret M; Alvarez I; Amouyel P; Athanasiu L; Bahrami S; Bailly H; Belbin O; Bergh S; Bertram L; Biessels GJ; Blennow K; Blesa R; Boada M; Boland A; Buerger K; Carracedo Á; Cervera-Carles L; Chene G; Claassen JAHR; Debette S; Deleuze JF; de Deyn PP; Diehl-Schmid J; Djurovic S; Dols-Icardo O; Dufouil C; Duron E; Düzel E; ; Fladby T; Fortea J; Frölich L; García-González P; Garcia-Martinez M; Giegling I; Goldhardt O; Gobom J; Grimmer T; Haapasalo A; Hampel H; Hanon O; Hausner L; Heilmann-Heimbach S; Helisalmi S; Heneka MT; Hernández I; Herukka SK; Holstege H; Jarholm J; Kern S; Knapskog AB; Koivisto AM; Kornhuber J; Kuulasmaa T; Lage C; Laske C; Leinonen V; Lewczuk P; Lleó A; de Munain AL; Lopez-Garcia S; Maier W; Marquié M; Mol MO; Montrreal L; Moreno F; Moreno-Grau S; Nicolas G; Nöthen MM; Orellana A; Pålhaugen L; Papma JM; Pasquier F; Perneczky R; Peters O; Pijnenburg YAL; Popp J; Posthuma D; Pozueta A; Priller J; Puerta R; Quintela I; Ramakers I; Rodriguez-Rodriguez E; Rujescu D; Saltvedt I; Sanchez-Juan P; Scheltens P; Scherbaum N; Schmid M; Schneider A; Selbæk G; Selnes P; Shadrin A; Skoog I; Soininen H; Tárraga L; Teipel S; ; Tijms B; Tsolaki M; Van Broeckhoven C; Van Dongen J; van Swieten JC; Vandenberghe R; Vidal JS; Visser PJ; Vogelgsang J; Waern M; Wagner M; Wiltfang J; Wittens MMJ; Zetterberg H; Zulaica M; van Duijn CM; Bjerke M; Engelborghs S; Jessen F; Teunissen CE; Pastor P; Hiltunen M; Ingelsson M; Andreassen OA; Clarimón J; Sleegers K; Ruiz A; Ramirez A; Cruchaga C; Lambert JC; van der Flier W
Acta Neuropathol; 2022 Nov; 144(5):821-842. PubMed ID: 36066633
[TBL] [Abstract][Full Text] [Related]
20. Comparison of CSF biomarkers in Down syndrome and autosomal dominant Alzheimer's disease: a cross-sectional study.
Fagan AM; Henson RL; Li Y; Boerwinkle AH; Xiong C; Bateman RJ; Goate A; Ances BM; Doran E; Christian BT; Lai F; Rosas HD; Schupf N; Krinsky-McHale S; Silverman W; Lee JH; Klunk WE; Handen BL; Allegri RF; Chhatwal JP; Day GS; Graff-Radford NR; Jucker M; Levin J; Martins RN; Masters CL; Mori H; Mummery CJ; Niimi Y; Ringman JM; Salloway S; Schofield PR; Shoji M; Lott IT; ;
Lancet Neurol; 2021 Aug; 20(8):615-626. PubMed ID: 34302786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
